Cardiac ontogenesis represents the first major functional morphogenetic event in human embryonic development. The heart begins to form around the third week of gestation, when mesodermal cells from the primary cardiac field migrate and differentiate under the influence of crucial growth factors, including BMP, FGF, and Wnt.
These cells give rise to two endocardial tubes which, under lateral and cranio-caudal movement, fuse along the midline to form the primitive heart tube. The newly formed structure divides into distinct segments, which will later become the anatomical regions of the heart:
Outflow Tract: will form the aorta and pulmonary trunk.
Cardiac Bulb: will contribute to the formation of the right ventricle and outflow tracts.
Primitive Ventricle: will become the left ventricle.
Primitive Atrium: will become the right and left atria.
Sinus Venosus: will contribute to the formation of the vena cavae and right atrium.
During the fourth week, the cardiac looping occurs, an essential process that gives the heart its double-loop configuration. The tube curves ventrally and rotates, resulting in the correct positioning of the heart's chambers: the right ventricle is pushed anteriorly and to the right, the left ventricle posteriorly and to the left, while the atria are positioned dorsally above the ventricles.
Following this, the complex process of septation begins, separating the primitive heart into four distinct chambers and establishing the systemic and pulmonary circuits:
The interatrial septum forms through the growth of the primum and secundum septa, leaving the foramen ovale for fetal blood flow.
The interventricular septum develops from the lower margin of the primitive ventricle and completes through fusion with the endocardial cushion.
The conotruncal septum, shaped by neural crest cells, separates the outflow tract into the aorta and pulmonary trunk.
In parallel, the myocardium differentiates from a simple contractile layer into a complex structure with a conduction system capable of rhythmically coordinating heart contractions. The sinoatrial node, atrioventricular node, and His bundle progressively emerge within the primitive myocardium.
Anomalies that may arise during these critical phases of morphogenesis include interventricular septal defects, conotruncal anomalies such as tetralogy of Fallot, and more complex conditions like persistent truncus arteriosus or transposition of the great arteries.
Heart maturation continues through the second and third trimesters with thickening of the myocardial walls, the formation of atrioventricular and semilunar valves, and development of the coronary system. At this point, the heart is fully differentiated and ready to support extrauterine circulation at birth.
Fetal Circulation
During intrauterine life, the fetal cardiovascular system adopts a unique configuration that allows the fetus to receive oxygen and nutrients via the placenta, as the lungs are not yet operational. The fetal circulation relies on a series of physiological shunts that minimize blood flow to the lungs and, to a lesser extent, the liver, optimizing oxygenation of vital organs such as the brain and heart.
Oxygen-rich blood from the placenta enters the fetus via the umbilical vein. A small portion perfuses the liver, while most is diverted directly to the inferior vena cava through the ductus venosus. This partially mixed blood enters the right atrium, where a cleverly arranged system of valves and septa directs the more oxygenated flow through the foramen ovale into the left atrium. From there, it passes into the left ventricle, is expelled into the ascending aorta, and distributed to the brain and fetal myocardium.
Less oxygenated blood, mainly from the superior vena cava, is directed to the right ventricle and pumped into the pulmonary artery. However, the high vascular resistance of the unventilated lungs forces most of this blood to bypass the pulmonary circuit, passing through the ductus arteriosus and flowing directly into the descending aorta.
The three main shunts that characterize fetal circulation are:
Ductus venosus, which diverts oxygenated blood from the liver to the inferior vena cava.
Foramen ovale, which allows blood to pass directly from the right atrium to the left atrium.
Ductus arteriosus, which connects the pulmonary artery to the descending aorta, bypassing the lungs.
This architecture ensures that the most oxygen-rich blood reaches the organs with the highest metabolic demand, while the pulmonary circulation remains minimally involved until birth.
With the first breath, lung expansion dramatically lowers pulmonary vascular resistance, allowing blood to flow into the lungs for oxygenation. The increased left atrial pressure compared to the right atrium causes the functional closure of the foramen ovale, while the cessation of umbilical flow stimulates the contraction of the ductus arteriosus and ductus venosus.
In the days and weeks following birth, these shunts anatomically obliterate: the foramen ovale closes and becomes the fossa ovalis, the ductus arteriosus becomes the ligamentum arteriosum, and the ductus venosus shrinks into the ligamentum venosum. Incomplete closure of these processes can lead to clinically relevant conditions, such as a patent ductus arteriosus or a patent foramen ovale, which require appropriate diagnostic and therapeutic attention.
Congenital Heart Defects: General Overview
Congenital heart defects represent the most common group of congenital malformations, with a global prevalence estimated between 6 and 12 per 1000 live births. These are structural abnormalities of the heart and great vessels that develop during embryonic life due to alterations in the complex processes of cardiac morphogenesis and septation.
The etiology of congenital heart defects is multifactorial, involving both genetic and environmental causes. Point mutations, chromosomal aberrations, and genetic syndromes (such as Down syndrome, DiGeorge syndrome, and trisomy 18) can disrupt the heart's developmental pathways. Environmental factors, such as maternal infections (rubella, cytomegalovirus), exposure to teratogenic drugs, or maternal conditions like uncontrolled diabetes, are also implicated in the genesis of these malformations.
From an embryological perspective, congenital heart defects can be classified based on the type of alteration:
Formation defects, where a structure fails to develop properly, such as in ventricular septal defects.
Division defects, due to improper separation of the chambers or outflow tracts, as in persistent truncus arteriosus.
Resorption defects, resulting from incomplete recanalization or apoptosis, such as in pulmonary stenosis.
Position defects, such as transposition of the great arteries or heterotaxy, where cardiac structures are abnormally positioned.
The clinical manifestations of congenital heart defects are highly variable. Some defects, such as patent foramen ovale, may remain asymptomatic throughout life, while others, like pulmonary atresia or persistent truncus arteriosus, cause severe symptoms within the first days of life. The main clinical presentations include persistent cyanosis, signs of congestive heart failure, growth retardation, and auscultatory abnormalities such as pathological heart murmurs.
Diagnosis is based on an integrated approach, starting with the physical examination and supplemented by instrumental investigations such as:
Transthoracic echocardiography, the first-choice test for anatomical and functional evaluation.
Transesophageal echocardiography, useful in complex cases or with limited acoustic windows.
Cardiac MRI and CT angiography, for detailed anatomical characterization.
Cardiac catheterization, reserved for cases requiring hemodynamic study or interventional planning.
Recent advances in fetal echocardiography have allowed the diagnosis of many congenital heart defects prenatally, improving perinatal management and therapeutic prospects.
The prognosis varies greatly depending on the type of malformation, the presence of associated anomalies, and the timeliness of treatment. Recent innovations in pediatric cardiac surgery, percutaneous intervention techniques, and neonatal intensive care have significantly increased the long-term survival of children with congenital heart defects. Today, many of these patients reach adulthood with a satisfactory quality of life, although they often require ongoing cardiological follow-up and, in some cases, additional surgeries or interventional procedures.
References
Sadler TW. Langman's Medical Embryology. Wolters Kluwer. 14th ed. 2019.
Moore KL, et al. The Developing Human: Clinically Oriented Embryology. Elsevier. 11th ed. 2019.
Hoffman JI, et al. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890-1900.
Bruneau BG. The developmental genetics of congenital heart disease. Nature. 2008;451(7181):943-948.
Srivastava D. Making or breaking the heart: from lineage determination to morphogenesis. Cell. 2006;126(6):1037-1048.
Anderson RH, et al. Understanding cardiac malformations: the role of cardiac embryology. Nat Rev Cardiol. 2009;6(11):670-679.
Reller MD, et al. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr. 2008;153(6):807-813.
Yuan S, et al. Genetic and epigenetic mechanisms in congenital heart diseases. Curr Opin Pediatr. 2016;28(5):626-631.
van der Linde D, et al. Birth prevalence of congenital heart disease worldwide. J Am Coll Cardiol. 2011;58(21):2241-2247.
Fahed AC, et al. Genetics of congenital heart disease: the glass half empty. Circ Res. 2013;112(4):707-720.
